Diseases
demyelinating polyneuropathy
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Overview
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms.
Symptoms
- tingling in your arms and legs.
- gradual weakening of your arms and legs.
- loss of reflexes.
- loss of balance and your ability to walk.
- loss of feeling in your arms and legs
Causes
- occurs when the body's immune system attacks the myelin sheaths around nerve cells, but exactly what triggers this is not clear.
Risk factors
- people in their 50s and 60s seem more likely to develop it than other age groups
- men are twice as likely as women to get the disease.
Diagnosis
- blood and urine tests
- a nerve conduction study to look for myelin damage
- a lumbar puncture.
Medicines used
Frequently asked questions
What is demyelinating polyneuropathy?
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder characterized by progressive weakness and impaired sensory function in the legs and arms.
What are the symptoms of demyelinating polyneuropathy?
tingling in your arms and legs., gradual weakening of your arms and legs., loss of reflexes., loss of balance and your ability to walk., loss of feeling in your arms and legs
What causes demyelinating polyneuropathy?
occurs when the body's immune system attacks the myelin sheaths around nerve cells, but exactly what triggers this is not clear.
Which medicines are used for demyelinating polyneuropathy?
immunoglobulin
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.